Citations

Mayo Clinic

Showing 10 of 108599 citations.

Managing Antiseizure Medications in Pregnancy
Freund, Brin , Johnson, Emily L. , Chen, Baibing , Johnson, Emily L , Kaplan, Peter W.

Neurology Clinical Practice | May 22, 2023 | Volume: 13 | Issue: 4 | Pages: No page available

10.1212/cpj.0000000000200169 | PMID 37223248 Get It

Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation
Boukens, Bastiaan J. , Scrocco, Chiara , Wilde, Arthur A.M. , Nademanee, Koonlawee , Haı̈ssaguerre, Michel , Behr, Elijah R. , Miles, Chris , Scrocco, Chiara , Wilde, Arthur A M , Nademanee, Koonlawee , Haissaguerre, Michel , Behr, Elijah Raphael , Coronel, Ruben

Circulation | May 22, 2023 | Volume: 147 | Issue: 21 | Pages: 1622-1633

10.1161/circulationaha.122.061924 | PMID 37216437 Get It

Brugada syndrome (BrS), early repolarization syndrome (ERS), and idiopathic ventricular fibrillation (iVF) have long been considered primary electrical disorders associated with malignant ventricular arrhythmia and sudden cardiac death. However, recent studies have revealed the presence of subtle microstructural abnormalities of the extracellular matrix in some cases of BrS, ERS, and iVF, particularly within right ventricular subepicardial myocardium. Substrate-based ablation within this region has been shown to ameliorate the electrocardiographic phenotype and to reduce arrhythmia frequency in BrS. Patients with ERS and iVF may also exhibit low-voltage and fractionated electrograms in the ventricular subepicardial myocardium, which can be treated with ablation. A significant proportion of patients with BrS and ERS, as well as some iVF survivors, harbor pathogenic variants in the voltage-gated sodium channel gene, SCN5A , but the majority of genetic susceptibility of these disorders is likely to be polygenic. Here, we postulate that BrS, ERS, and iVF may form part of a spectrum of subtle subepicardial cardiomyopathy. We propose that impaired sodium current, along with genetic and environmental susceptibility, precipitates a reduction in epicardial conduction reserve, facilitating current-to-load mismatch at sites of structural discontinuity, giving rise to electrocardiographic changes and the arrhythmogenic substrate.
Cultural Hierarchies, Leadership, and Employee Happiness
Biggadike, Chris , Ahumada‐Tello, Eduardo , Evans, Richard , Wehde, Mark

IEEE Engineering Management Review | May 22, 2023 | Volume: 51 | Issue: 3 | Pages: 8-12

10.1109/emr.2023.3275188 Get It

Self-Efficacy for Self-Regulated Learning Mediates Association between Implicit Theories of Willpower and Learning Strategies
Worick, Cara E., Osterhage, Jennifer L. , Keller, Peggy S. , Usher, Ellen L. , Love, Abigail M. A.

The Journal of Experimental Education | May 22, 2023 | Volume: 92 | Issue: 3 | Pages: 502-512

10.1080/00220973.2023.2209861 Get It

Cryo-EM structure of the Mon1–Ccz1–RMC1 complex reveals molecular basis of metazoan RAB7A activation
Yong, Xin, Jia, Guowen , Liu, Zhe , Zhou, Chunzhuang, Yi, Jiamin, Tang, Yingying , Chen, Li , Wang, Yuan , Sun, Qingxiang , Billadeau, Daniel D. , Su, Zhaoming , Sun, Qingxiang , Billadeau, Daniel D , Su, Zhaoming , Jia, Da , Yong, Xin, Yi, Jiamin, Chen, Lu , Jia, Da

Proceedings of the National Academy of Sciences | May 22, 2023 | Volume: 120 | Issue: 22 | Pages: No page available

10.1073/pnas.2301725120 | PMID 37216550 Get It

Understanding of the evolution of metazoans from their unicellular ancestors is a fundamental question in biology. In contrast to fungi which utilize the Mon1–Ccz1 dimeric complex to activate the small GTPase RAB7A, metazoans rely on the Mon1–Ccz1–RMC1 trimeric complex. Here, we report a near-atomic resolution cryogenic-electron microscopy structure of the Drosophila Mon1–Ccz1–RMC1 complex. RMC1 acts as a scaffolding subunit and binds to both Mon1 and Ccz1 on the surface opposite to the RAB7A-binding site, with many of the RMC1-contacting residues from Mon1 and Ccz1 unique to metazoans, explaining the binding specificity. Significantly, the assembly of RMC1 with Mon1–Ccz1 is required for cellular RAB7A activation, autophagic functions and organismal development in zebrafish. Our studies offer a molecular explanation for the different degree of subunit conservation across species, and provide an excellent example of how metazoan-specific proteins take over existing functions in unicellular organisms.
Plain Language Summary of the MAIA Study of Daratumumab Plus Lenalidomide and Dexamethasone for the Treatment of People with Newly Diagnosed Multiple Myeloma
Kumar, Shaji , Plesner, Torben , Orlowski, Robert Z. , Hulin, Cyrille , Goldschmidt, Hartmut , Macro, Margaret , Leleu, Xavier , Wang, Jianping , Rampelbergh, Rian Van , Uhlar, Clarissa, Vermeulen, Jessica, Duran, Joana , Borgsten, Fredrik, Usmani, Saad Z. , Orlowski, Robert Z. , Usmani, Saad , Facon, Thierry T.F. , Moreau, Philippe , Bahlis, Nizar Jacques , Basu, Supratik , Nahi, Hareth , Quach, Hang , Perrot, Aurore , Weisel, Katja C , Raje, Noopur , Frenzel, Laurent

Future Oncology | May 22, 2023 | Volume: 19 | Issue: 13 | Pages: 887-895

10.2217/fon-2023-0082 | PMID 37212642 Get It

A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising From Pancreatic Cysts
Wald, Abigail I. , Spagnolo, Daniel M. , Grupillo, Maria, Lai, Yi-Tak, O’Broin-Lennon, Anne Marie, Park, Walter G. , Pfau, Patrick , Kubiliun, Nisa , Easler, Jeffrey J. , Dam, Aamir, Mok, Shaffer , Wallace, Michael B. , Kumbhari, Vivek , Marsh, Wallis, Thakkar, Shyam , Fairley, Kimberly, Bhat, Yasser M., Nasr, John , Khalid, Asif , Fasanella, Kenneth, Chennat, Jennifer, Singh, Harkirat , Sarkaria, Savreet, Slivka, Adam, Gabbert, Charles, Sawas, Tarek , Tielleman, Thomas , Vanderveldt, Hendrikus Dutch, Tavakkoli, Anna , Smith, Katelyn, Hruban, Ralph H. , Paniccia, Alessandro , Zureikat, Amer H., Lee, Kenneth K. , Ongchin, Melanie , Zeh, Herbert J. , Minter, Rebecca M., He, Jin , Wallace, Michael B , Nikiforova, Marina N. , Melan, Melissa A. , Brand, Randall E. , McGrath, Kevin , Polanco, Patricio Marcelo , DeWitt, John M. , Boone, Brian A. , Afghani, Elham , Ramrakhiani, Sanjay , Skef, Wasseem , Thiruvengadam, Nikhil Ravi , Das, Rohit Kumar , Smith, Lynette M. , Bell, Phoenix , Nikiforov, Yuri E. , Singhi, Aatur Dilip

Annals of Surgery | May 22, 2023 | Volume: 278 | Issue: 4 | Pages: e789-e797

10.1097/sla.0000000000005904 | PMID 37212422 Get It

Objective: We report the development and validation of a combined DNA/RNA next-generation sequencing (NGS) platform to improve the evaluation of pancreatic cysts. Background and Aims: Despite a multidisciplinary approach, pancreatic cyst classification, such as a cystic precursor neoplasm, and the detection of high-grade dysplasia and early adenocarcinoma (advanced neoplasia) can be challenging. NGS of preoperative pancreatic cyst fluid improves the clinical evaluation of pancreatic cysts, but the recent identification of novel genomic alterations necessitates the creation of a comprehensive panel and the development of a genomic classifier to integrate the complex molecular results. Methods: An updated and unique 74-gene DNA/RNA-targeted NGS panel (PancreaSeq Genomic Classifier) was created to evaluate 5 classes of genomic alterations to include gene mutations (e.g., KRAS, GNAS, etc.), gene fusions and gene expression. Further, CEA mRNA (CEACAM5) was integrated into the assay using RT-qPCR. Separate multi-institutional cohorts for training (n=108) and validation (n=77) were tested, and diagnostic performance was compared to clinical, imaging, cytopathologic, and guideline data. Results: Upon creation of a genomic classifier system, PancreaSeq GC yielded a 95% sensitivity and 100% specificity for a cystic precursor neoplasm, and the sensitivity and specificity for advanced neoplasia were 82% and 100%, respectively. Associated symptoms, cyst size, duct dilatation, a mural nodule, increasing cyst size, and malignant cytopathology had lower sensitivities (41–59%) and lower specificities (56–96%) for advanced neoplasia. This test also increased the sensitivity of current pancreatic cyst guidelines (IAP/Fukuoka and AGA) by >10% and maintained their inherent specificity. Conclusions: PancreaSeq GC was not only accurate in predicting pancreatic cyst type and advanced neoplasia but also improved the sensitivity of current pancreatic cyst guidelines.
Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
Pardanani, Animesh

American Journal of Hematology | May 22, 2023 | Volume: 98 | Issue: 7 | Pages: 1097-1116

10.1002/ajh.26962 | PMID 37309222 Get It

AbstractOverviewSystemic mastocytosis (SM) results from clonal proliferation of mast cells (MC) in extracutaneous organs.DiagnosisThe major criterion is presence of multifocal MC clusters in the bone marrow and/or extracutaneous organs. Minor diagnostic criteria include elevated serum tryptase level, MC CD25/CD2/CD30 expression, and presence of activating KIT mutations.Risk StratificationEstablishing SM subtype as per the International Consensus Classification/World Health Organization classification systems is an important first step. Patients either have indolent/smoldering SM (ISM/SSM) or advanced SM, including aggressive SM (ASM), SM with associated myeloid neoplasm (SM‐AMN), and mast cell leukemia. Identification of poor‐risk mutations (i.e., ASXL1, RUNX1, SRSF2, NRAS) further refines the risk stratification. Several risk models are available to help assign prognosis in SM patients.ManagementTreatment goals for ISM patients are primarily directed toward anaphylaxis prevention/symptom control/osteoporosis treatment. Patients with advanced SM frequently need MC cytoreductive therapy to reverse disease‐related organ dysfunction. Tyrosine kinase inhibitors (TKI) (midostaurin, avapritinib) have changed the treatment landscape in SM. While deep biochemical, histological and molecular responses have been documented with avapritinib treatment, its efficacy as monotherapy against a multimutated AMN disease component in SM‐AMN patients remains unclear. Cladribine continues to have a role for MC debulking, whereas interferon‐α has a diminishing role in the TKI era. Treatment of SM‐AMN primarily targets the AMN component, particularly if an aggressive disease such as acute leukemia is present. Allogeneic stem cell transplant has a role in such patients. Imatinib has a therapeutic role only in the rare patient with an imatinib‐sensitive KIT mutation.
Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex
Kandhaya‐Pillai, Renuka , Kirkland, James L. , Oshima, Junko , Miró‐Mur, Francesc , Alijotas‐Reig, Jaume , Tchkonia, Tamar , Schwartz, Simó

Aging | May 22, 2023 | Volume: 15 | Issue: 10 | Pages: 4012-4034

10.18632/aging.204743 | PMID 37219418 Get It

Impact of type 2 diabetes on mortality, cause of death, and treatment in chronic lymphocytic leukemia
Rotbain, Emelie Curovic , Allmer, Cristine, Rostgaard, Klaus , Andersen, Michael Asger , Vainer, Noomi , Parikh, Sameer A. , Rabe, Kari G. , Hjalgrim, Henrik , Frederiksen, Henrik , Niemann, Carsten Utoft , Parikh, Sameer A , Chaffee, Kari G. , Frederiksen, Henrik , Cunha‐Bang, Caspar da , Slager, Susan L.

American Journal of Hematology | May 22, 2023 | Volume: 98 | Issue: 8 | Pages: 1236-1245

10.1002/ajh.26964 | PMID 37212419 Get It

AbstractAge‐related comorbid conditions are exceedingly common in patients with chronic lymphocytic leukemia (CLL). As the prevalence of type 2 diabetes (T2D) is predicted to double during the next two decades, a better understanding of the interplay between CLL and T2D is of increasing importance. In this study, analyses were performed in parallel in two separate cohorts, based on Danish national registers and the Mayo Clinic CLL Resource. The primary outcomes were overall survival (OS) from time of CLL diagnosis, OS from time of treatment, and time to first treatment (TTFT), studied using Cox proportional hazard regression analysis and Fine‐Gray regression analysis. In the Danish CLL cohort, the prevalence of T2D was 11%, in the Mayo CLL cohort, it was 12%. Patients with CLL and T2D had shorter OS both from time of diagnosis and from first‐line treatment for were less likely to receive treatment for CLL compared with patients with CLL and without T2D. The increased mortality was largely driven by an increased risk of death due to infections, especially in the Danish cohort. The findings of this study emphasize a substantial subgroup of CLL patients with co‐occurring T2D with an inferior prognosis and a possible unmet treatment need requiring additional interventions and further research.